← Browse by Condition
Medical Condition
atherosclerosis
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 1, Phase 4, Phase 3
ClinicalMetric tracks all active clinical trials for atherosclerosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — atherosclerosis Clinical Trials
How many clinical trials are currently recruiting for atherosclerosis?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for atherosclerosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for atherosclerosis?
atherosclerosis research spans Phase 1 (1 trial), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a atherosclerosis clinical trial?
Eligibility criteria for atherosclerosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 3 1
Phase 4 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04410003 Phase 1
Recruiting
Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis
Enrollment
100 pts
Location
Canada
Sponsor
Western University, Canada
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT05906810
Recruiting
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis
Enrollment
90 pts
Location
Italy
Sponsor
University of Catania
NCT06694012
Recruiting
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Enrollment
2,000 pts
Location
Japan
Sponsor
Osaka Metropolitan University
NCT06579807
Recruiting
Cardiac Rehabilitation and Coronary Artery Disease
Enrollment
50 pts
Location
Brazil
Sponsor
Instituto Nacional de Cardiolo...
NCT06263244 Phase 3
Recruiting
Specifying the Anti-inflammatory Effects of Ziltivekimab
Enrollment
40 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
NCT05235464
Recruiting
High Protein Diet and Atherosclerosis
Enrollment
24 pts
Location
United States
Sponsor
University of Missouri-Columbi...
NCT02381301
Recruiting
Biomarkers and Cardiac CT
Enrollment
5,000 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
NCT06406998
Recruiting
Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD
Enrollment
5,461,222 pts
Location
South Korea
Sponsor
Samsung Medical Center
NCT06402747 Phase 4
Recruiting
Clopidogrel Versus Cilostazol on Vessels
Enrollment
120 pts
Location
South Korea
Sponsor
Seoul National University Bund...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology